Corvus Pharmaceuticals Provides Business Update and Reports
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib...
Source: globenewswire.com
Stay updated with breaking news from Partner Led Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib...